▲ BUY
6
/ 10
Conviction
$ Value
$48K
Shares
6,000
Price
$8
Filed
Sep 10
▶ Why this score? (6/10)
- ✓ Open market buy (+3)
- ✓ C-suite insider (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Sun Nelson
Title
Chief Financial Officer
CIK
0002045377
Roles
Officer
Transaction Details
Transaction Date
2025-09-09
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
105,484
Footnotes
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.00 to $8.20 per share, inclusive. The reporting person undertakes to provide Aardvark Therapeutics, Inc. ("Aardvark"), any security holder of Aardvark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Filing Info
Sun Nelson's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-09 | AARD | A | $0 |
| 2025-12-11 | AARD | ▲ | $43K |
| 2025-09-09 | AARD | ▲ | $48K ★ |
| 2025-06-11 | AARD | A | $0 |
Other Insiders at AARD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Lee Tien-Li
Chief Executive Officer
|
— | — | 2026-02-09 |
|
Sun Nelson
Chief Financial Officer
|
— | — | 2026-02-09 |
|
Jaiman Manasi
Chief Medical Officer
|
— | — | 2026-02-09 |